Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-19-001573 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
74.62% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-152.06% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
254.09% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 13th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
18.72% · OPTIONAL · VALID
Gross margin 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
49.69% · CORE · VALID
Operating margin 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
-184.56% · CORE · VALID
R&D intensity 13th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
25.54% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
14.83% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1492.81%
Current 74.62%
Delta -1418.20% Cash Generation Increased
Previous -458.15%
Current -152.06%
Delta 306.09% Growth Increased
Previous -65.69%
Current 254.09%
Delta 319.78% Inventory Pressure Decreased
Previous 22.65%
Current 18.72%
Delta -3.93% Margin Decreased
Previous 55.25%
Current 49.69%
Delta -5.56% Profitability Increased
Previous -513.98%
Current -184.56%
Delta 329.42% R And D Intensity Decreased
Previous 71.89%
Current 25.54%
Delta -46.35% Sbc Intensity Decreased
Previous 175.70%
Current 14.83%
Delta -160.87% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.